active
ACTIVE SINCE: 2018

Tshwane Insulin Project (TIP)

Develop a health-care provider and technology- supported approach to safely manage high-risk type 2 diabetes patients on insulin at primacy care centers in the Tshwane district in South Africa.
SGDS CONTRIBUTING TO:
SHOW SUB-TARGETS + HIDE SUB-TARGETS -
MEMBER COMPANIES:
Academia or research institute 1

Lilly has partnered with the University of Pretoria in South Africa to support a research project aimed at initiating and titrating insulin in type 2 diabetes patients in primary care. Led by nurses, supported by CHWs and doctors, TIP has proven that patients can be safely initiated on insulin in primary care settings. Interim results show that patients on the TIP program have reached reductions in HbA1C in excess of 2%, bringing them closer to optimal glycemic control. In addition, through TIP hundreds of healthcare workers have been empowered and capacitated to better manage diabetes and hypertension patients.

Geographic Reach
Disease Area
  • Non-communicable diseases
See Disease Areas
Target Population
  • People with low incomes
Partner organizations
Academia or research institute

University of Pretoria